UA88255C2 - Immunostimulatory oligonucleotide - Google Patents
Immunostimulatory oligonucleotideInfo
- Publication number
- UA88255C2 UA88255C2 UAA200500665A UA2005000665A UA88255C2 UA 88255 C2 UA88255 C2 UA 88255C2 UA A200500665 A UAA200500665 A UA A200500665A UA 2005000665 A UA2005000665 A UA 2005000665A UA 88255 C2 UA88255 C2 UA 88255C2
- Authority
- UA
- Ukraine
- Prior art keywords
- immunostimulatory oligonucleotide
- phosphodiester
- oligonucleotide
- internucleotide linkage
- relates
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40447902P | 2002-08-19 | 2002-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA88255C2 true UA88255C2 (en) | 2009-10-12 |
Family
ID=35306229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200500665A UA88255C2 (en) | 2002-08-19 | 2003-08-19 | Immunostimulatory oligonucleotide |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1688192B (es) |
GT (1) | GT200300176A (es) |
TN (1) | TNSN05052A1 (es) |
UA (1) | UA88255C2 (es) |
ZA (1) | ZA200500963B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102864152B (zh) * | 2005-11-07 | 2015-11-18 | 艾德拉药物股份有限公司 | 包含经修饰的免疫刺激性二核苷酸的基于寡核苷酸的化合物之免疫刺激特性 |
NZ575437A (en) * | 2006-09-27 | 2012-02-24 | Coley Pharm Gmbh | Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
EP2620428B1 (en) | 2010-09-24 | 2019-05-22 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
AU2013287630B2 (en) * | 2012-07-13 | 2017-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
AU2014268836B2 (en) * | 2013-05-18 | 2018-08-02 | Aduro Biotech, Inc. | Compositions and methods for activating "stimulator of interferon gene"-dependent signalling |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1271733A (zh) * | 2000-04-04 | 2000-11-01 | 中国预防医学科学院病毒学研究所 | 对人免疫细胞有特异免疫刺激活性的CpG寡核酸 |
-
2003
- 2003-08-19 GT GT200300176A patent/GT200300176A/es unknown
- 2003-08-19 ZA ZA200500963A patent/ZA200500963B/en unknown
- 2003-08-19 CN CN03824039.4A patent/CN1688192B/zh not_active Expired - Fee Related
- 2003-08-19 UA UAA200500665A patent/UA88255C2/ru unknown
-
2005
- 2005-02-18 TN TNP2005000052A patent/TNSN05052A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
GT200300176A (es) | 2004-03-29 |
CN1688192A (zh) | 2005-10-26 |
ZA200500963B (en) | 2006-10-25 |
TNSN05052A1 (en) | 2007-05-14 |
CN1688192B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200206612B (en) | Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction. | |
WO2003027313A3 (en) | SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE | |
AU2168902A (en) | Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol | |
AP2004003026A0 (en) | Methods for treating ocular neovascular diseases. | |
WO2003048324A3 (en) | Antisense modulation of phospholipid scramblase 3 expression | |
WO2001048190A8 (en) | Therapeutic uses of lna-modified oligonucleotides | |
WO2004081021A3 (en) | Oligonucleotide mimetics | |
WO2003030823A3 (en) | Combinations for the treatment of immunoinflammatory disorders | |
WO2001032832A3 (en) | Antisense inhibition of nucleolin expression | |
WO2003046132A3 (en) | Antisense modulation of myd88 expression | |
UA87433C2 (ru) | Гонадотропины для стимулирования фолликулогенеза | |
WO2003050137A3 (en) | Toll-like receptor 4 mutations | |
MXPA05010414A (es) | Uso de clusterina para el tratamiento y/o prevencion de enfermedades neurologicas perifericas. | |
UA88255C2 (en) | Immunostimulatory oligonucleotide | |
WO2005020908A3 (en) | Selective inhibitors of stat-3 activation and uses thereof | |
AU2180501A (en) | Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide | |
WO2004037168A3 (en) | Treatment of pancreatitis with amylin | |
EP0979309A4 (en) | OLIGONUCLEOTIDES WITH IMPROVED BIOAVAILABILITY | |
WO2002087604A8 (de) | Präparationen von vitamin e in kombination mit afamin | |
WO2004078142A3 (en) | Compositions and methods for preventing and treating endotoxin-related diseases and conditions | |
IL139303A0 (en) | Treatment of arthritis and other similar conditions | |
WO2001085152A3 (en) | R-eliprodil for treating glaucoma | |
WO2004014299A3 (en) | Antisense modulation of resistin expression | |
WO2002041836A3 (en) | Antisense modulation of src-1 expression | |
WO2003031576A3 (en) | Antisense modulation of inhibitor-kappa b kinase-gamma expression |